This course aims to provide a comprehensive overview and update of current issues relating to medicines use in pregnancy and human teratogens. It will be of relevance to a wide range of health professionals; in particular, midwives, obstetricians, GPs, geneticists , paediatricians & pharmacists, and to those working in women’s health or pharmacovigilance and medicines regulation.
The course will provide an overview of:
Fetal development and the principles of human teratology
Known and emerging human teratogens of relevance today
Possible consequences of not adequately treating the mother
Effects of specific illnesses on pregnancy outcome
Risk-benefit analysis of medicine use in a pregnancy and lactation
Pregnancy pharmacovigilance and clinical application of pregnancy safety data
Risk communication in the context of human teratogens
Speakers include internationally recognised experts in teratology, fetal development, obstetrics, maternal medicine and public health.